Entrar/Registro  
INICIO ENGLISH
 
Gaceta Médica de México
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Gaceta Médica de México >Año 2016, No. S2


García-Carrasco M, Mendoza-Pinto C, Ayón-Aguilar J, Soto-Santillán P, Rodríguez-Gallegos A, Escamilla-Márquez MA, Méndez-Martínez S
Niveles séricos de vitamina D en pacientes con lupus eritematoso sistémico (LES) y su asociación con la actividad de la enfermedad: estudio longitudinal
Gac Med Mex 2016; 152 (S2)

Idioma: Español
Referencias bibliográficas: 36
Paginas: 32-37
Archivo PDF: 106.61 Kb.


Texto completo




RESUMEN

Objetivo: determinar las modificaciones en el tiempo de los niveles séricos de 25 hidroxivitamina D (25(OH)D) en pacientes mexicanas con LES y su relación con la actividad de la enfermedad. Material y métodos: estudio observacional y longitudinal. Se incluyeron mujeres con diagnóstico de LES. Se determinaron los niveles de 25(OH)D basales y a dos años de seguimiento, así como la actividad de la enfermedad con la variante mexicana del Systemic Lupus Erythematosus Disease Activity Index (MEX-SLEDAI). En las pacientes con niveles no óptimos de 25(OH)D en la determinación basal se suplementó o aumentó la dosis de calcitriol. Resultados: se incluyeron 105 pacientes con LES, edad media 49.4 ± 11 años. Los niveles séricos de 25(OH)D se incrementaron (basal 20 ± 6.8 ng/ml vs. seguimiento 22.7 ± 7.7; p = ‹ 0.001). No hubo diferencias en la actividad de la enfermedad (basal 1.7 ± 1.9 puntos vs. 1.1 ± 1.7 puntos; p = 0.7). Los niveles séricos de 25(OH)D en el seguimiento no se correlacionaron con actividad de la enfermedad, p = 0.7. Tampoco hubo correlaciones entre la variación del puntaje MEX-SLEDAI y los niveles 25(OH)D, p = 0.87. Conclusión: las mujeres mexicanas con LES tuvieron un incremento de niveles séricos de 25(OH)D. No se observó relación entre niveles de 25(OH)D y la actividad de la enfermedad.


Palabras clave: Lupus eritematoso sistémico, Vitamina D, MEX-SLEDAI.


REFERENCIAS

  1. Lim SS, Drenkard C. Epidemiology of systemic lupus erythematosus: capturing the butterfly. Curr Rheumatol Rep. 2008;10:265-72.

  2. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-21.

  3. Katsiari CG, Liossis SN, Sfikakis PP. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum. 2010;39:491-503.

  4. Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2010;12:207.

  5. Smith CK, Kaplan MJ. The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol. 2015;27:448-53.

  6. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878-88.

  7. Feld J, Isenberg D. Why and how should we measure disease activity and damage in lupus? Presse Med. 2014;43:151-6.

  8. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96:365-408.

  9. Wei R, Christakos S. Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients. 2015;7:8251-60.

  10. Adorini L, Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol. 2009:251-73.

  11. Peelen E, Knippenberg S, Muris AH, et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev. 2011;10:733-43.

  12. Clifford J, Rosen MD. Vitamin D insufficiency. N Engl J Med. 2011;364: 248-54.

  13. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martnez-Berriotxoa, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008;47: 920-3.

  14. Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit. 2011;17:CR711-8.

  15. Thudi A, Yin S, Wandstrat AE, Li QZ, Olsen NJ. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci. 2008;335(2):99-104.

  16. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti- Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009;20:427-33.

  17. Sumethkul K, Boonyaratavej S, Kitumnuaypong T, et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33:1461-7.

  18. Schneider L, Dos Santos AS, Santos M, da Silva Chakr RM, Monticielo OA. Vitamin D and systemic lupus erythematosus: state of the art. Clin Rheumatol. 2014;33:1033-8.

  19. García-Carrasco M, Romero JL. Vitamin D and autoimmune rheumatic disease. Reumatol Clin. 2015;11:333-4.

  20. Sundström P, Salzer J. Vitamin D and multiple sclerosis-from epidemiology to prevention. Acta Neurol Scand. 2015;132:5661.

  21. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebocontrolled trial. J Rheumatol. 2013;40:265-72.

  22. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51:544-51.

  23. Mandal M, Tripathy R, Panda AK, et al. Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther. 2014;16:R49.

  24. Mok C, Birmingham D, Ho L, Hebert L, Song H, Rovin B. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus. 2012;21:36-42.

  25. Aranow C, Kamen DL, Dall’Era M, et al. Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(7):1848-57

  26. Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 2013;65:1865-71.

  27. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken). 2010;62:1160-5.

  28. Galarza-Maldonado C, Kourilovitch MR, Molineros JE, et al. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus. Autoimmun Rev. 2010;10:108-11.

  29. Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-26.

  30. Schneider L, Colar da Silva AC, Werres Junior LC, et al. Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus. Lupus. 2015;24:1191-7.

  31. Andreoli L, Dall’Ara F, Piantoni S, et al. A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus. 2015;24:499-506.

  32. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford). 2012;51:644-52.

  33. Lertratanakul A, Wu P, Dyer A, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort .Arthritis Care Res (Hoboken). 2014;66:1167-76.

  34. Kiani AN, Fang H, Magder LS, Petri M. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford). 2013;52:2071-6.

  35. Clark P, Vivanco-Muñoz N, Piña JT, et al. High prevalence of hipovitaminosis D in Mexican aged 14 years and older and its correlation with parathyroid hormone. Arch Osteoporos. 2015;10:225.

  36. Yap, KS, Morand EF. Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis. 2015;18:242-9.



>Revistas >Gaceta Médica de México >Año2016, No. S2
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019